FR2386521A1 - Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments - Google Patents

Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments

Info

Publication number
FR2386521A1
FR2386521A1 FR7809266A FR7809266A FR2386521A1 FR 2386521 A1 FR2386521 A1 FR 2386521A1 FR 7809266 A FR7809266 A FR 7809266A FR 7809266 A FR7809266 A FR 7809266A FR 2386521 A1 FR2386521 A1 FR 2386521A1
Authority
FR
France
Prior art keywords
secoprostaglandins
interphenylene
aza
dioxathia
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7809266A
Other languages
English (en)
Other versions
FR2386521B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2386521A1 publication Critical patent/FR2386521A1/fr
Application granted granted Critical
Publication of FR2386521B1 publication Critical patent/FR2386521B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des interphénylène 8-aza-9-dioxothia-11,12-secoprostaglandines. On prépare des interphénylène 8-aza-9-dioxothia-11,12-secoprostaglandines par l'alcoylation en deux étapes de l'anion d'un (alcoyl inférieur)sulfonamide, R** 1SO2 NH2 , en utilisant d'abord un composé de la formule :
FR7809266A 1977-04-04 1978-03-30 Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments Granted FR2386521A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/783,998 US4112236A (en) 1977-04-04 1977-04-04 Interphenylene 8-aza-9-dioxothia-11,12-secoprostaglandins

Publications (2)

Publication Number Publication Date
FR2386521A1 true FR2386521A1 (fr) 1978-11-03
FR2386521B1 FR2386521B1 (fr) 1982-11-19

Family

ID=25131052

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7809266A Granted FR2386521A1 (fr) 1977-04-04 1978-03-30 Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments

Country Status (16)

Country Link
US (1) US4112236A (fr)
AR (1) AR225727A1 (fr)
AU (1) AU516540B2 (fr)
BE (1) BE865624A (fr)
DE (1) DE2814321A1 (fr)
DK (1) DK146578A (fr)
ES (1) ES468510A1 (fr)
FR (1) FR2386521A1 (fr)
GB (1) GB1576688A (fr)
IE (1) IE46699B1 (fr)
IT (1) IT1103475B (fr)
LU (1) LU79356A1 (fr)
NL (1) NL7802824A (fr)
PT (1) PT67847B (fr)
SE (1) SE7803606L (fr)
ZA (1) ZA781885B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3641099A1 (de) * 1986-12-02 1988-06-09 Hoechst Ag Verfahren zur herstellung von 4-(2'-chlorethyl)benzoesaeure
WO1998027976A1 (fr) 1996-12-20 1998-07-02 Pfizer Inc. Prevention et traitement d'affections osseuses avec des agonistes de la prostaglandine e2 selectifs du sous-type de recepteur ep2
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
US6124314A (en) 1997-10-10 2000-09-26 Pfizer Inc. Osteoporosis compounds
UA67754C2 (uk) * 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
IL141120A0 (en) 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CA2895512C (fr) 2012-12-17 2021-10-19 Parion Sciences, Inc. Derives de chloro-pyrazine carboxamide utiles dans le traitement de maladies favorisees par une hydratation insuffisante des muqueuses
CN108658876A (zh) 2012-12-17 2018-10-16 帕里昂科学公司 3,5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2284320A1 (fr) * 1974-09-13 1976-04-09 Merck & Co Inc Secoprostaglandines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE410185B (sv) 1973-04-25 1979-10-01 Merck & Co Inc Forfarande for framstellning av seko - prostaglandiner med vasodilaterande och blodplettaggregationshemmande effekt

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2284320A1 (fr) * 1974-09-13 1976-04-09 Merck & Co Inc Secoprostaglandines

Also Published As

Publication number Publication date
BE865624A (fr) 1978-10-03
IE46699B1 (en) 1983-08-24
NL7802824A (nl) 1978-10-06
US4112236A (en) 1978-09-05
DK146578A (da) 1978-10-05
FR2386521B1 (fr) 1982-11-19
AU3436678A (en) 1979-09-27
DE2814321A1 (de) 1978-10-05
AU516540B2 (en) 1981-06-11
PT67847B (en) 1980-04-04
IT1103475B (it) 1985-10-14
LU79356A1 (fr) 1978-11-27
ZA781885B (en) 1979-06-27
IT7848626A0 (it) 1978-03-28
GB1576688A (en) 1980-10-15
ES468510A1 (es) 1979-09-16
IE780632L (en) 1978-10-04
SE7803606L (sv) 1978-10-05
AR225727A1 (es) 1982-04-30
PT67847A (en) 1978-04-01

Similar Documents

Publication Publication Date Title
FR2386521A1 (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
FR2358891A1 (fr) Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires
YU56995A (sh) Soli derivata indola
FR2446289A1 (fr) Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue
FR2381763A1 (fr) Dibenzo(b-e) (diazepines-1,4) et leur utilisation comme antischizophreniques
FR2359830A1 (fr) 6-alcoyl-pyrimidines utilisables comme medicament, notamment contre la malaria
PT83104A (en) Novel guanidinomethylbenzoic acid derivatives
FR2361340A1 (fr) Nouvelles anilines substituees utilisables comme medicament
IE780922L (en) 1,3,5-s-HEXAHYDROSUBSTITUTED TRIAZINES
FR2387955A1 (fr) Derives de l'aniline utilisables comme medicament
FR2395269A1 (fr) Procede de preparation de 7,8-dihydro-14-hydroxynormorphinone
DK607783A (da) Nitroaliphatiske forbindelser
FR2436150A1 (fr) Derives de 3'',4''-diacyltylosine utiles comme medicaments
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
FR2361326A1 (fr) Derives de cyclohexane utiles comme agents odoriferants
FR2392958A1 (fr) Nouveaux amino-acides fluores utiles comme medicament
FR2404009A1 (fr) 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques
FR2381035A1 (fr) Urees substituees utiles comme medicaments et procedes pour leur preparation
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
FR2359131A1 (fr) Agents cardiovasculaires a base de thiazoles
FR2401167A1 (fr) Derives de thienothiazine utiles comme medicaments
ES2021515A6 (es) Procedimiento para la preparacion de compuestos derivados de isotiazolo-piridona azetidinil substituidos.
ES2012519A6 (es) Procedimiento para preparar compuestos polifluorados.
ES8207507A1 (es) Un procedimiento para la preparacion de un compuesto de platino.
FR2443457A1 (fr) Derives de 1-phenyl-2-amino-1-propanol, leur procede de preparation et leur utilisation comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse